 This week CureTalk’s Myeloma Cure Panel was launched and successfully. A panel of seven myeloma patients and bloggers, myeloma expert, and over 30 people listening in to the teleconference, Myeloma Cure Panel was aired live on BlogTalk Radio on the 22 August 2012 @ 1pm EST. Dr. Ravi Vij, the expert on the panel provided all participants with comprehensive data touching upon the research efforts in multiple myeloma in the last 10 years and on the ongoing efforts that would bear fruit in the coming few years. New drugs, maintenance therapy with lenalidomide, dosing of myeloma drugs, and treatment of high risk and low risk patients were some of the topics brought to fore by the panelists. Dr. Vij, answered questions over a time of one hour. The audio of the panel discussion is available here. |
 Read more about CurePanel, here, here, and here. |
 CureTalk Buzzz…
- FDA approved Marqibo for ALL - New research studies on multiple myeloma - West Nile virus alert in US - Average life expectancy to be 100 |
 Using Kyprolis in multiple myeloma patients... - How to use Kyprolis/carfilzomib - Psychosis prediction by thought disorder - Revlimid maintenance recommended by NCCN - Placental stem cell therapy for cancer cure |
 Pat Killingsworth has been continuing his myeloma journey and to catch up with him click here, here, and here. |
| We will be back with more interesting research news, until then stay healthy and smiling. |
Related posts:
- The CureTalk Round-Up: Myeloma Cure Panel, Interviews, Myeloma Research, Clinical Trials, and Diabetes Research
- Dr. Ravi Vij To Be Myeloma Expert on Cure Panel
- The CureTalk Weekly Round-Up
- Myeloma Cure Panel Discussion with Dr. Ravi Vij – A Summary
- The CureTalk Weekly Round Up: Interviews, Multiple Myeloma research, Kyprolis/Carfilzomib FDA approval, and new Malaria Drug Target